Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
AssigneeVirogenetics Corporation
InventorsEnzo Paoletti, James Tartaglia, William I. Cox
Life of this patent
Estimating the term…
Abstract
Attenuated vaccinia or canarypox recombinant viruses containing DNA coding for a cytokine and/or a tumor associated antigen, as well as methods and compositions employing the viruses, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The DNA can code for at least one of: human tumor necrosis factor; nuclear phosphoprotein p53, wildtype or mutant; human melanoma-associated antigen; IL-2; IFN.gamma.; IL-4; GMCSF; IL-12; B7; erb-B-2 and carcinoembryonic antigen. The recombinant viruses and gene products therefrom are useful for cancer therapy.
Claims5
A recombinant poxvirus containing therein an exogenous DNA sequence encoding a cytokine, an exogenous DNA sequence encoding a tumor-associated antigen, or exogenous DNA sequences encoding a cytokine and a tumor associated antigen in a nonessential region of the poxvirus genome wherein the poxvirus expresses the exogenous DNA and the poxvirus is ALVAC or an attenuated canarypox virus wherein said canarypox virus is attenuated through more than 200 serial passages on chick embryo fibroblasts, a master seed therefrom was subjected to four successive plaque purifications under agar, from which a plaque clone was amplified through five additional passages.
Dependencies are inferred from the claim text.